Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Myotonic syndromes.

Ami Mankodi1, Charles A Thornton

  • 1Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

Current Opinion in Neurology
|September 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.

Muscle & nerve·2026
Same author

Prospective Study of Video Hand Opening Time as a Quantitative Measurement of Myotonia in Patients With Myotonic Dystrophy Type 1.

Neurology·2026
Same author

An Antibody-Oligonucleotide Conjugate for Myotonic Dystrophy Type 1.

The New England journal of medicine·2026
Same author

Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1): Protocol of an international natural history study.

PloS one·2025
Same author

Elimination of myotonia improves myopathy in a muscleblind knockout model of myotonic dystrophy.

bioRxiv : the preprint server for biology·2025
Same author

Study of Testosterone and Recombinant Human Growth Hormone in Facioscapulohumeral Muscular Dystrophy.

Neurology. Genetics·2025
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
Same journal

Functional movement disorders: diagnosis, pathophysiology, and treatment.

Current opinion in neurology·2026
Same journal

Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum.

Current opinion in neurology·2026
See all related articles

Myotonic syndromes, including myotonic dystrophies, are linked to specific gene mutations. Recent findings suggest a pathogenic RNA produced from these mutations may cause disease, particularly affecting muscle fibers.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Myotonic syndromes encompass non-dystrophic myotonias and myotonic dystrophies.
  • Non-dystrophic myotonias result from mutations in skeletal muscle-specific chloride or sodium channel genes.
  • Myotonic dystrophies are characterized by specific genetic mutations.

Purpose of the Study:

  • To review recent advancements in the clinical and molecular genetic understanding of myotonic syndromes.
  • To focus on the molecular genetics and clinical manifestations of myotonic dystrophies.
  • To highlight the role of RNA in the pathogenesis of myotonic dystrophies.

Main Methods:

  • Review of recent scientific literature on myotonic syndromes.
  • Analysis of genetic studies identifying mutations in myotonic dystrophies.

Related Experiment Videos

  • Investigation of molecular mechanisms underlying RNA toxicity in muscle fibers.

    • Main Results:

    • Myotonic dystrophy type 1 is caused by a CTG repeat expansion.
    • Myotonic dystrophy type 2 (proximal myotonic myopathy) is also caused by a DNA expansion mutation.
    • Mutant RNA is retained in nuclear inclusions and interferes with nuclear functions like RNA processing, potentially causing toxic effects in muscle fibers.

    Conclusions:

    • Myotonic dystrophy may be the first genetic disease caused by a pathogenic RNA.
    • The precise mechanism of RNA-mediated disease is not fully understood.
    • It remains unclear if this RNA-mediated process affects non-muscle tissues in myotonic dystrophy.